Cargando…
Effects of sunitinib on endothelial dysfunction, metabolic changes, and cardiovascular risk indices in renal cell carcinoma
BACKGROUND: Sunitinib is a standard treatment for metastatic renal cell carcinoma (RCC). Currently, the data available on the effects of sunitinib on endothelial dysfunction, metabolic changes, and cardiovascular (CV) risk factors are limited, and we aimed to evaluate these aspects in patients with...
Autores principales: | Lai, Silvia, Amabile, Maria Ida, Mazzaferro, Sandro, Mitterhofer, Anna Paola, Mazzarella, Angelo, Galani, Alessandro, Imbimbo, Giovanni, Cianci, Rosario, Pasquali, Marzia, Molfino, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286450/ https://www.ncbi.nlm.nih.gov/pubmed/32270594 http://dx.doi.org/10.1002/cam4.2910 |
Ejemplares similares
-
Association between Multidimensional Prognostic Index and Hospitalization and Mortality among Older Adults with Chronic Kidney Disease on Conservative or on Replacement Therapy
por: Lai, Silvia, et al.
Publicado: (2020) -
Association between Cognitive Impairment and Malnutrition in Hemodialysis Patients: Two Sides of the Same Coin
por: Rotondi, Silverio, et al.
Publicado: (2023) -
Prebiotic Therapy with Inulin Associated with Low Protein Diet in Chronic Kidney Disease Patients: Evaluation of Nutritional, Cardiovascular and Psychocognitive Parameters
por: Lai, Silvia, et al.
Publicado: (2020) -
Calcitriol/calcifediol ratio: An indicator of vitamin D hydroxylation efficiency?
por: Pasquali, Marzia, et al.
Publicado: (2015) -
Fatigue in Patients on Chronic Hemodialysis: The Role of Indoleamine 2,3-Dioxygenase (IDO) Activity, Interleukin-6, and Muscularity
por: Molfino, Alessio, et al.
Publicado: (2023)